27 27 Chemicalname=Levothyroxine Sodium EP Impurity J,Levothyroxine Sodium EP Impurity J,CAS=CAS=70-40-6,Impurities of Levothyroxine,reference standards of Levothyroxine

Levothyroxine Sodium EP Impurity J

IMPURITIES

Product Details

CAT No.# CS-I-00089
Category Impurities
CAS 70-40-6
Molecular Weight 525
Molecular Formula C15H13I2NO4
Stock Status: In-Stock   View COA
Purity: >98%
Synonyms: Levothyroxine Sodium EP Impurity J;L-3,3- Diiodothyronine;L-3,3- Diiodothyronine; (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3-iodophenyl]propanoic acid;Alanine, 3-[4-(4-hydroxy-3-iodophenoxy)-3-iodophenyl]-, L- (8CI);(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3-iodophenyl]propanoic acid.
Application Notes: Impurity in commercial preparation of Levothyroxine.
Shipping: Free Shipping for worldwide on order above 2000 USD
Levothyroxine Sodium EP Impurity J Worldwide Suppliers of Levothyroxine Sodium EP Impurity J Impurities Clearsynth CS-I-00089

Product rating: 9 Levothyroxine Sodium EP Impurity J based on 20 ratings

  1. Impurities
  2. Levothyroxine Sodium EP Impurity J

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Crisaborole m-Isomer
15. Riluzole (1604337)
16. Pheniramine impurity B
17. Palbociclib N-Glucuronide
18. Carpropamid
19. Olmesartan N1-Trityl Impurity
20. Aripiprazole (1042634)


Smileys:
IC1=C(C=CC(CC(N)C(O)=O)=C1)OC2=CC(I)=C(O)C=C2



This page contains information about Levothyroxine Sodium EP Impurity J Cas 70-40-6 and its Impurities.

Levothyroxine Sodium EP Impurity J Levothyroxine Sodium EP Impurity J Worldwide Suppliers of Levothyroxine Sodium EP Impurity J Impurities Clearsynth 70-40-6

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."